Company Filing History:
Years Active: 1999-2010
Title: The Innovative Journey of Daniel Jasserand in Pharmaceutical Patents
Introduction
Daniel Jasserand, an accomplished inventor based in Hannover, Germany, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of seven patents, Jasserand's work primarily focuses on the development of advanced compounds with therapeutic potential. His innovations have been pivotal in the creation of new treatments, showcasing his dedication to improving healthcare through scientific research.
Latest Patents
Jasserand's latest patents highlight his expertise in developing novel pharmaceutical formulations. One of his notable inventions includes 1-amidomethylcarbonyl-piperidine compounds, which offers methods and intermediate products for their production, alongside pharmaceutical formulations containing these compounds. Another significant patent involves 4-substituted 1-amidomethylcarbonyl-piperidine compounds that exhibit motilin-agonistic properties and their acid addition salts, including processes and intermediate products for preparation and treatment applications.
Additionally, Jasserand's work with NK1 and NK2 antagonists has resulted in the creation of 3-cyanonaphthalene-1-carboxylic acid perhydroxyalkylmethyl-piperazine compounds. These compounds are designed to be antagonistic to tachykinin receptors, presenting innovative pharmaceutical compositions and methodologies for tackling various diseases and disorders.
Career Highlights
Throughout his career, Daniel Jasserand has demonstrated a profound commitment to pharmaceutical innovation. His role at Solvay Pharmaceuticals GmbH has been instrumental in advancing research initiatives that lead to a better understanding of complex compounds and their therapeutic applications. Jasserand's expertise in both the practical and theoretical aspects of drug development has allowed him to secure multiple patents, underscoring his impact on the field.
Collaborations
Collaboration has been a cornerstone of Jasserand's success. Working alongside esteemed colleagues like Reinhard Brueckner and Ulf Preuschoff, he has fostered an environment of shared knowledge and innovation. These collaborative efforts have greatly contributed to the development of essential pharmaceutical compounds that are critical to current medical challenges.
Conclusion
Daniel Jasserand's journey as an inventor in Hannover, Germany, reflects a commitment to innovation in the pharmaceutical industry. His impressive array of patents and collaborative work with leading researchers exemplify the impact that dedicated inventors can have on healthcare advancements. As Jasserand continues to push the boundaries of pharmaceutical science, his contributions will undoubtedly pave the way for future breakthroughs in medical treatments.